ND-L02-s0201
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Nitto Denko Corporation
Overview
ND-L02-s0201 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ND-L02-s0201 clinical trials
Explore related
Medical disclaimer. This page summarizes research about ND-L02-s0201 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.